Exact Sciences Q1 2024 GAAP EPS $(0.60) Misses $(0.48) Estimate, Sales $638.000M Beat $627.365M Estimate
Author: Benzinga Newsdesk | May 08, 2024 04:10pm
Exact Sciences (NASDAQ:
EXAS) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.48) by 25 percent. The company reported quarterly sales of $638.000 million which beat the analyst consensus estimate of $627.365 million by 1.70 percent. This is a 5.90 percent increase over sales of $602.450 million the same period last year.
Posted In: EXAS